STOCK TITAN
  1. Home
  2. Sec-filings
  3. HLN
  4. [6-K] Haleon plc Current Report (Foreign Issuer)

Haleon (NYSE: HLN) lifts H1 2026 dividend and posts half-year results

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Haleon plc announced that its 2026 half year results statement for the year ending 31 December 2026 is now available on its investor website and through the UK Financial Conduct Authority’s National Storage Mechanism.

The Board declared an H1 2026 interim dividend of 2.4 pence per ordinary share, a 9% increase on the 2025 interim dividend and in line with the policy of paying about one third of the prior full-year dividend at the interim stage. The dividend is expected to be paid on 17 September 2026 to holders of ordinary shares and ADS on the register as of 14 August 2026, with ex-dividend dates of 13 August 2026 for ordinary shares and 14 August 2026 for ADS. A Dividend Reinvestment Programme is available with an election deadline of 28 August 2026. Management will provide a recorded results presentation and a Q&A session for analysts and shareholders on 30 July 2026.

Positive

  • None.

Negative

  • None.
H1 2026 interim dividend 2.4 pence per ordinary share Declared interim dividend for H1 2026
Dividend increase vs 2025 interim 9% Increase on the interim dividend in 2025
Dividend payment date 17 September 2026 Expected payment date for H1 2026 interim dividend
Dividend record date 14 August 2026 Record date for holders of ordinary shares and ADS
DRIP election deadline 28 August 2026 Deadline for ordinary shareholders to elect into DRIP
Q&A call time 9:00am BST Time of analyst and shareholder Q&A on 30 July 2026
interim dividend financial
"the Board has declared a H1 2026 interim dividend of 2.4 pence per ordinary share"
An interim dividend is a cash payment a company declares and often pays before its annual results are finalized, similar to a mid‑year bonus paid from current profits. It matters to investors because it delivers immediate income, signals the company’s short‑term cash strength and confidence in ongoing earnings, and can influence share price and investor expectations about future payouts.
Dividend Reinvestment Programme (DRIP) financial
"For ordinary shareholders wishing to participate in the Dividend Reinvestment Programme (DRIP)"
American Depositary Shares (ADS) market
"to holders of ordinary shares and US American Depositary Shares (ADS) on the register"
American depositary shares (ADS) are a way for investors in the United States to buy shares of foreign companies without dealing with the complexities of international markets. They represent ownership in a foreign company's stock and are traded on U.S. exchanges, making it easier and more convenient for Americans to invest internationally. ADSs allow investors to diversify their portfolios with foreign companies while using familiar trading platforms.
Disclosure and Transparency Rules regulatory
"regulated information as per 6.3.7R of the Disclosure and Transparency Rules"
Rules that require companies to provide accurate, timely and complete information about their finances, operations, risks and governance to regulators, investors and the public. They matter to investors because consistent, clear reporting is like a reliable scoreboard: it makes it easier to compare companies, spot problems early, reduce surprises and fraud, and form better expectations about future performance and value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

FAQ

What interim dividend has Haleon (HLN) declared for H1 2026?
Haleon has declared an H1 2026 interim dividend of 2.4 pence per ordinary share. This represents a 9% increase on the 2025 interim dividend and aligns with its policy of paying about one third of the prior full-year dividend at the interim stage.

When will Haleon (HLN) pay the H1 2026 interim dividend and what is the record date?
The H1 2026 interim dividend is expected to be paid on 17 September 2026. Shareholders and ADS holders must be on the register as of the 14 August 2026 record date to receive the dividend.

What are the ex-dividend dates for Haleon (HLN) ordinary shares and ADS for the H1 2026 dividend?
The ex-dividend date is 13 August 2026 for Haleon ordinary shareholders and 14 August 2026 for ADS holders. Investors purchasing on or after these dates will not receive the H1 2026 interim dividend.

Does Haleon (HLN) offer a Dividend Reinvestment Programme for the H1 2026 dividend?
Yes. Ordinary shareholders can participate in Haleon’s Dividend Reinvestment Programme (DRIP). The election deadline for the H1 2026 interim dividend DRIP is 28 August 2026, and the programme is provided by Equiniti Financial via Shareview.

Where can investors access Haleon (HLN) 2026 half year results?
Haleon’s 2026 half year results statement is available on its investor website and through the UK FCA’s National Storage Mechanism. A direct PDF link via the London Stock Exchange’s RNS service is also provided.

Will Haleon (HLN) host a call or presentation on the 2026 half year results?
Yes. A recorded results presentation will be available shortly after 7:00am BST on 30 July 2026, followed by a Q&A session at 9:00am BST. Dial-in details are provided for analysts and shareholders wishing to ask questions.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of July 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F ☒
 
Form 40-F ☐
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
30 July 2026 - “2026 Half Year Results”
99.2
30 July 2026 - “2026 Half Year Results”
 
 
 
 
99.1
 
Haleon plc: 2026 Half Year Results
 
30 July 2026: Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces its half year results statement for the year ending 31 December 2026 is available at http://www.rns-pdf.londonstockexchange.com/rns/4443O_1-2026-7-29.pdf.
 
The half year results statement will also be available on the Haleon website www.haleon.com/investors, and the results have been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
 
Dividend
Consistent with our policy to pay approximately one third of the prior year full year dividend as the interim dividend the Board has declared a H1 2026 interim dividend of 2.4 pence per ordinary share, up 9% on the interim dividend in 2025. This interim dividend is expected to be paid on 17 September 2026 to holders of ordinary shares and US American Depositary Shares (ADS) on the register as of 14 August 2026 (the record date). The ex-dividend date is expected to be 13 August 2026 for ordinary shareholders and 14 August 2026 for holders of ADS. For ordinary shareholders wishing to participate in the Dividend Reinvestment Programme (DRIP), the election deadline for the DRIP is 28 August 2026. The DRIP is provided by Equiniti Financial www.shareview.co.uk.
 
Subject to market conditions and Board approval, Haleon expects to grow its ordinary dividend at least in line with adjusted earnings.
 
Presentation for analysts and shareholders
A recorded results presentation by Brian McNamara, Chief Executive Officer, and Dawn Allen, Chief Financial Officer, will be available shortly after 7:00am BST (8:00 am CEST) on 30 July 2026 and can be accessed at www.haleon.com/investors. This will be followed by a Q&A session at 9:00am BST (10:00am CEST).
 
For analysts and shareholders wishing to ask questions, please use the dial-in details below which will have a Q&A facility:
 
UK:
+44 (0) 808 189 0158
US:
+1 855 979 6654
All other:
+44 (0) 203 936 2999
Passcode:
081063
 
An archived webcast of the Q&A call will be available later on the day of the results and can be accessed at www.haleon.com/investors.
 
This information contains regulated information as per 6.3.7R of the Disclosure and Transparency Rules of the Financial Conduct Authority.
 
Amanda Mellor
Company Secretary
 
Enquiries
 
Investors
Media
 
Jo Russell
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.
 
For more information, please visit www.haleon.com.
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: July 30, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary


Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document

Press Releases